{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T09:22:12Z","timestamp":1789809732715,"version":"4.0.1"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,5,8]],"date-time":"2015-05-08T00:00:00Z","timestamp":1431043200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Hepatology Rep"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s11901-015-0260-z","type":"journal-article","created":{"date-parts":[[2015,5,7]],"date-time":"2015-05-07T08:23:28Z","timestamp":1430987008000},"page":"119-127","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Pathogenesis of Hepatocellular Carcinoma Development in Non-alcoholic Fatty Liver Disease"],"prefix":"10.1007","volume":"14","author":[{"given":"Kirti","family":"Shetty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-hyun","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilma","family":"Jogunoori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lopa","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,5,8]]},"reference":[{"key":"260_CR1","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1053\/j.gastro.2012.04.001","volume":"142","author":"NYZ Chalasani","year":"2012","unstructured":"Chalasani NYZ, Lavine JE, Diehl AM, Brunt EM, Cusi K, Charlton M, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology. 2012;142:1592\u2013609.","journal-title":"Gastroenterology"},{"key":"260_CR2","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1053\/j.gastro.2014.07.056","volume":"147","author":"MM Yeh","year":"2014","unstructured":"Yeh MM, Brunt EM. Pathological features of fatty liver disease. Gastroenterology. 2014;147:754\u201364.","journal-title":"Gastroenterology"},{"key":"260_CR3","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2036.2011.04724.x","volume":"34","author":"G Vernon","year":"2011","unstructured":"Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther. 2011;34:274\u201385.","journal-title":"Aliment Pharmacol Ther"},{"key":"260_CR4","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/aje\/kws448","volume":"178","author":"M Lazo","year":"2013","unstructured":"Lazo M, Hernaez R, Eberhardt MS, Bonekamp S, Kamel I, Guallar E, et al. Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988\u20131994. Am J Epidemiol. 2013;178:38\u201345.","journal-title":"Am J Epidemiol"},{"key":"260_CR5","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1053\/j.gastro.2010.09.038","volume":"140","author":"CD Williams","year":"2011","unstructured":"Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, Contreras M, et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology. 2011;140:124\u201331.","journal-title":"Gastroenterology"},{"key":"260_CR6","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S1665-2681(19)31922-2","volume":"6","author":"D Amarapurkar","year":"2007","unstructured":"Amarapurkar D, Kamani P, Patel N, Gupte P, Kumar P, Agal S, et al. Prevalence of non-alcoholic fatty liver disease: population based study. Ann Hepatol. 2007;6:161\u20133.","journal-title":"Ann Hepatol"},{"key":"260_CR7","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nrgastro.2013.34","volume":"10","author":"GC Farrell","year":"2013","unstructured":"Farrell GC, Wong VW, Chitturi S. NAFLD in Asia\u2014as common and important as in the West. Nat Rev Gastroenterol Hepatol. 2013;10:307\u201318.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"260_CR8","doi-asserted-by":"crossref","first-page":"6419","DOI":"10.3748\/wjg.v13.i47.6419","volume":"13","author":"YJ Zhou","year":"2007","unstructured":"Zhou YJ, Li YY, Nie YQ, Ma JX, Lu LG, Shi SL, et al. Prevalence of fatty liver disease and its risk factors in the population of South China. World J Gastroenterol. 2007;13:6419\u201324.","journal-title":"World J Gastroenterol"},{"key":"260_CR9","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1046\/j.1440-1746.2002.02846.x","volume":"17","author":"K Omagari","year":"2002","unstructured":"Omagari K, Kadokawa Y, Masuda J, Egawa I, Sawa T, Hazama H, et al. Fatty liver in non-alcoholic non-overweight Japanese adults: incidence and clinical characteristics. J Gastroenterol Hepatol. 2002;17:1098\u2013105.","journal-title":"J Gastroenterol Hepatol"},{"key":"260_CR10","doi-asserted-by":"crossref","unstructured":"White DL, Kanwal F, El-Serag HB. Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review. Clin Gastroenterol Hepatol. 2012;10:1342\u201359. This is a meta-analysis of multiple studies showing epidemiologic evidence for the association between NAFLD and HCC.","DOI":"10.1016\/j.cgh.2012.10.001"},{"key":"260_CR11","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1053\/gast.2002.34168","volume":"123","author":"E Bugianesi","year":"2002","unstructured":"Bugianesi E, Leone N, Vanni E, Marchesini G, Brunello F, Carucci P, et al. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology. 2002;123:134\u201340.","journal-title":"Gastroenterology"},{"key":"260_CR12","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/hep.510290347","volume":"29","author":"SH Caldwell","year":"1999","unstructured":"Caldwell SH, Oelsner DH, Iezzoni JC, Hespenheide EE, Battle EH, Driscoll CJ. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology. 1999;29:664\u20139.","journal-title":"Hepatology"},{"key":"260_CR13","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1053\/jhep.2002.33324","volume":"35","author":"V Ratziu","year":"2002","unstructured":"Ratziu V, Bonyhay L, Di Martino V, Charlotte F, Cavallaro L, Sayegh-Tainturier MH, et al. Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis. Hepatology. 2002;35:1485\u201393.","journal-title":"Hepatology"},{"key":"260_CR14","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1053\/jhep.2002.36939","volume":"36","author":"JA Marrero","year":"2002","unstructured":"Marrero JA, Fontana RJ, Su GL, Conjeevaram HS, Emick DM, Lok AS. NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States. Hepatology. 2002;36:1349\u201354.","journal-title":"Hepatology"},{"key":"260_CR15","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1186\/1471-2407-13-335","volume":"13","author":"SS Lee","year":"2013","unstructured":"Lee SS, Jeong SH, Byoun YS, Chung SM, Seong MH, Sohn HR, et al. Clinical features and outcome of cryptogenic hepatocellular carcinoma compared to those of viral and alcoholic hepatocellular carcinoma. BMC Cancer. 2013;13:335.","journal-title":"BMC Cancer"},{"key":"260_CR16","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/ng.257","volume":"40","author":"S Romeo","year":"2008","unstructured":"Romeo S, Kozlitina J, Xing C, Pertsemlidis A, Cox D, Pennacchio LA, et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet. 2008;40:1461\u20135.","journal-title":"Nat Genet"},{"key":"260_CR17","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/ajg.2013.476","volume":"109","author":"AG Singal","year":"2014","unstructured":"Singal AG, Manjunath H, Yopp AC, Beg MS, Marrero JA, Gopal P, et al. The effect of PNPLA3 on fibrosis progression and development of hepatocellular carcinoma: a meta-analysis. Am J Gastroenterol. 2014;109:325\u201334.","journal-title":"Am J Gastroenterol"},{"key":"260_CR18","unstructured":"World Health Organization. Obesity situation and trends. 2015. www.who.int\/topics\/obesity\/en\/ . Accessed 12 Feb 2015"},{"key":"260_CR19","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"KG Alberti","year":"2009","unstructured":"Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120:1640\u20135.","journal-title":"Circulation"},{"key":"260_CR20","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1093\/annonc\/mdt204","volume":"24","author":"S Schlesinger","year":"2013","unstructured":"Schlesinger S, Aleksandrova K, Pischon T, Jenab M, Fedirko V, Trepo E, et al. Diabetes mellitus, insulin treatment, diabetes duration, and risk of biliary tract cancer and hepatocellular carcinoma in a European cohort. Ann Oncol. 2013;24:2449\u201355.","journal-title":"Ann Oncol"},{"key":"260_CR21","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/j.1365-2036.2010.04271.x","volume":"31","author":"D Saunders","year":"2010","unstructured":"Saunders D, Seidel D, Allison M, Lyratzopoulos G. Systematic review: the association between obesity and hepatocellular carcinoma\u2014epidemiological evidence. Aliment Pharmacol Ther. 2010;31:1051\u201363.","journal-title":"Aliment Pharmacol Ther"},{"key":"260_CR22","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/sj.bjc.6603932","volume":"97","author":"SC Larsson","year":"2007","unstructured":"Larsson SC, Wolk A. Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies. Br J Cancer. 2007;97:1005\u20138.","journal-title":"Br J Cancer"},{"key":"260_CR23","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0140-6736(08)60269-X","volume":"371","author":"AG Renehan","year":"2008","unstructured":"Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008;371:569\u201378.","journal-title":"Lancet"},{"key":"260_CR24","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.3748\/wjg.v16.i29.3603","volume":"16","author":"W Blonski","year":"2010","unstructured":"Blonski W, Kotlyar DS, Forde KA. Non-viral causes of hepatocellular carcinoma. World J Gastroenterol. 2010;16:3603\u201315.","journal-title":"World J Gastroenterol"},{"key":"260_CR25","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/hep.24397","volume":"54","author":"TM Welzel","year":"2011","unstructured":"Welzel TM, Graubard BI, Zeuzem S, El-Serag HB, Davila JA, McGlynn KA. Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database. Hepatology. 2011;54:463\u201371.","journal-title":"Hepatology"},{"key":"260_CR26","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1185\/03007995.2010.506375","volume":"26","author":"A Sanyal","year":"2010","unstructured":"Sanyal A, Poklepovic A, Moyneur E, Barghout V. Population-based risk factors and resource utilization for HCC: US perspective. Curr Med Res Opin. 2010;26:2183\u201391.","journal-title":"Curr Med Res Opin"},{"key":"260_CR27","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.cgh.2011.01.023","volume":"9","author":"K Yasui","year":"2011","unstructured":"Yasui K, Hashimoto E, Komorizono Y, Koike K, Arii S, Imai Y, et al. Characteristics of patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma. Clin Gastroenterol Hepatol. 2011;9:428\u201333.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"260_CR28","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1053\/jhep.2000.9033","volume":"32","author":"MP Bralet","year":"2000","unstructured":"Bralet MP, Regimbeau JM, Pineau P, Dubois S, Loas G, Degos F, et al. Hepatocellular carcinoma occurring in nonfibrotic liver: epidemiologic and histopathologic analysis of 80 French cases. Hepatology. 2000;32:200\u20134.","journal-title":"Hepatology"},{"key":"260_CR29","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/hep.22734","volume":"49","author":"V Paradis","year":"2009","unstructured":"Paradis V, Zalinski S, Chelbi E, Guedj N, Degos F, Vilgrain V, et al. Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: a pathological analysis. Hepatology. 2009;49:851\u20139.","journal-title":"Hepatology"},{"key":"260_CR30","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00204-012-0931-2","volume":"87","author":"RN Aravalli","year":"2013","unstructured":"Aravalli RN, Cressman EN, Steer CJ. Cellular and molecular mechanisms of hepatocellular carcinoma: an update. Arch Toxicol. 2013;87:227\u201347.","journal-title":"Arch Toxicol"},{"key":"260_CR31","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1146\/annurev.immunol.021908.132629","volume":"27","author":"IN Crispe","year":"2009","unstructured":"Crispe IN. The liver as a lymphoid organ. Annu Rev Immunol. 2009;27:147\u201363.","journal-title":"Annu Rev Immunol"},{"key":"260_CR32","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1002\/hep.25674","volume":"56","author":"JK Stauffer","year":"2012","unstructured":"Stauffer JK, Scarzello AJ, Jiang Q, Wiltrout RH. Chronic inflammation, immune escape, and oncogenesis in the liver: a unique neighborhood for novel intersections. Hepatology. 2012;56:1567\u201374.","journal-title":"Hepatology"},{"key":"260_CR33","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nature02924","volume":"431","author":"E Pikarsky","year":"2004","unstructured":"Pikarsky E, Porat RM, Stein I, Abramovitch R, Amit S, Kasem S, et al. NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature. 2004;431:461\u20136.","journal-title":"Nature"},{"key":"260_CR34","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0168-8278(02)00064-8","volume":"37","author":"P Liu","year":"2002","unstructured":"Liu P, Kimmoun E, Legrand A, Sauvanet A, Degott C, Lardeux B, et al. Activation of NF-kappa B, AP-1 and STAT transcription factors is a frequent and early event in human hepatocellular carcinomas. J Hepatol. 2002;37:63\u201371.","journal-title":"J Hepatol"},{"key":"260_CR35","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nrgastro.2010.213","volume":"8","author":"T Luedde","year":"2011","unstructured":"Luedde T, Schwabe RF. NF-kappaB in the liver\u2014linking injury, fibrosis and hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 2011;8:108\u201318.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"260_CR36","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ccr.2009.12.048","volume":"17","author":"G He","year":"2010","unstructured":"He G, Yu GY, Temkin V, Ogata H, Kuntzen C, Sakurai T, et al. Hepatocyte IKKbeta\/NF-kappaB inhibits tumor promotion and progression by preventing oxidative stress-driven STAT3 activation. Cancer Cell. 2010;17:286\u201397.","journal-title":"Cancer Cell"},{"key":"260_CR37","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/cr.2010.183","volume":"21","author":"G He","year":"2011","unstructured":"He G, Karin M. NF-kappaB and STAT3\u2014key players in liver inflammation and cancer. Cell Res. 2011;21:159\u201368.","journal-title":"Cell Res"},{"key":"260_CR38","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/ng.2256","volume":"44","author":"C Guichard","year":"2012","unstructured":"Guichard C, Amaddeo G, Imbeaud S, Ladeiro Y, Pelletier L, Maad IB, et al. Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma. Nat Genet. 2012;44:694\u20138.","journal-title":"Nat Genet"},{"key":"260_CR39","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/ng.2391","volume":"44","author":"J Huang","year":"2012","unstructured":"Huang J, Deng Q, Wang Q, Li KY, Dai JH, Li N, et al. Exome sequencing of hepatitis B virus-associated hepatocellular carcinoma. Nat Genet. 2012;44:1117\u201321.","journal-title":"Nat Genet"},{"key":"260_CR40","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.canlet.2012.10.035","volume":"340","author":"H Nakagawa","year":"2013","unstructured":"Nakagawa H, Shibata T. Comprehensive genome sequencing of the liver cancer genome. Cancer Lett. 2013;340:234\u201340.","journal-title":"Cancer Lett"},{"key":"260_CR41","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2009.10.014","volume":"139","author":"D Iliopoulos","year":"2009","unstructured":"Iliopoulos D, Hirsch HA, Struhl K. An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation. Cell. 2009;139:693\u2013706.","journal-title":"Cell"},{"key":"260_CR42","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.cell.2009.12.052","volume":"140","author":"EJ Park","year":"2010","unstructured":"Park EJ, Lee JH, Yu GY, He G, Ali SR, Holzer RG, et al. Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell. 2010;140:197\u2013208.","journal-title":"Cell"},{"key":"260_CR43","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1158\/0008-5472.CAN-06-3075","volume":"67","author":"NK Saxena","year":"2007","unstructured":"Saxena NK, Sharma D, Ding X, Lin S, Marra F, Merlin D, et al. Concomitant activation of the JAK\/STAT, PI3K\/AKT, and ERK signaling is involved in leptin-mediated promotion of invasion and migration of hepatocellular carcinoma cells. Cancer Res. 2007;67:2497\u2013507.","journal-title":"Cancer Res"},{"key":"260_CR44","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1210\/er.2011-1015","volume":"33","author":"M Dalamaga","year":"2012","unstructured":"Dalamaga M, Diakopoulos KN, Mantzoros CS. The role of adiponectin in cancer: a review of current evidence. Endocr Rev. 2012;33:547\u201394.","journal-title":"Endocr Rev"},{"key":"260_CR45","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.jhep.2009.01.027","volume":"50","author":"M Vinciguerra","year":"2009","unstructured":"Vinciguerra M, Carrozzino F, Peyrou M, Carlone S, Montesano R, Benelli R, et al. Unsaturated fatty acids promote hepatoma proliferation and progression through downregulation of the tumor suppressor PTEN. J Hepatol. 2009;50:1132\u201341.","journal-title":"J Hepatol"},{"key":"260_CR46","doi-asserted-by":"crossref","first-page":"12093","DOI":"10.1074\/jbc.M510660200","volume":"281","author":"H Malhi","year":"2006","unstructured":"Malhi H, Bronk SF, Werneburg NW, Gores GJ. Free fatty acids induce JNK-dependent hepatocyte lipoapoptosis. J Biol Chem. 2006;281:12093\u2013101.","journal-title":"J Biol Chem"},{"key":"260_CR47","doi-asserted-by":"crossref","unstructured":"Khandekar MJ, Cohen P, Spiegelman BM. Molecular mechanisms of cancer development in obesity. Nat Rev Cancer. 2011;11:886\u201395. This review highlights recent advances in our understanding between obesity and HCC.","DOI":"10.1038\/nrc3174"},{"key":"260_CR48","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.bcp.2004.05.029","volume":"68","author":"C Alexia","year":"2004","unstructured":"Alexia C, Fallot G, Lasfer M, Schweizer-Groyer G, Groyer A. An evaluation of the role of insulin-like growth factors (IGF) and of type-I IGF receptor signalling in hepatocarcinogenesis and in the resistance of hepatocarcinoma cells against drug-induced apoptosis. Biochem Pharmacol. 2004;68:1003\u201315.","journal-title":"Biochem Pharmacol"},{"key":"260_CR49","doi-asserted-by":"crossref","first-page":"7124","DOI":"10.3390\/ijms15057124","volume":"15","author":"C Li","year":"2014","unstructured":"Li C, Yang W, Zhang J, Zheng X, Yao Y, Tu K, et al. SREBP-1 has a prognostic role and contributes to invasion and metastasis in human hepatocellular carcinoma. Int J Mol Sci. 2014;15:7124\u201338.","journal-title":"Int J Mol Sci"},{"key":"260_CR50","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/1469-0691.12140","volume":"19","author":"J Aron-Wisnewsky","year":"2013","unstructured":"Aron-Wisnewsky J, Gaborit B, Dutour A, Clement K. Gut microbiota and non-alcoholic fatty liver disease: new insights. Clin Microbiol Infect. 2013;19:338\u201348.","journal-title":"Clin Microbiol Infect"},{"key":"260_CR51","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.numecd.2012.02.007","volume":"22","author":"D Compare","year":"2012","unstructured":"Compare D, Coccoli P, Rocco A, Nardone OM, De Maria S, Carteni M, et al. Gut\u2013liver axis: the impact of gut microbiota on non alcoholic fatty liver disease. Nutri, Metab, Cardiovasc Dis : NMCD. 2012;22:471\u20136.","journal-title":"Nutri, Metab, Cardiovasc Dis : NMCD"},{"key":"260_CR52","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/ni.2231","volume":"13","author":"L Franchi","year":"2012","unstructured":"Franchi L, Munoz-Planillo R, Nunez G. Sensing and reacting to microbes through the inflammasomes. Nat Immunol. 2012;13:325\u201332.","journal-title":"Nat Immunol"},{"key":"260_CR53","doi-asserted-by":"crossref","unstructured":"Henao-Mejia J, Elinav E, Jin C, Hao L, Mehal WZ, Strowig T, et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature. 2012;482:179\u201385. This important study demonstrates that inflammasome deficiency leads to transmissible dysbiosis in co-housed mice, leading to NASH.","DOI":"10.1038\/nature10809"},{"key":"260_CR54","doi-asserted-by":"crossref","unstructured":"De Minicis S, Rychlicki C, Agostinelli L, Saccomanno S, Candelaresi C, Trozzi L, et al. Dysbiosis contributes to fibrogenesis in the course of chronic liver injury in mice. Hepatology. 2014;59:1738\u201349. This is a key study showing the link between dysbiosis and fibrogenesis in chronic liver disease.","DOI":"10.1002\/hep.26695"},{"key":"260_CR55","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/cas.12118","volume":"104","author":"N Ohtani","year":"2013","unstructured":"Ohtani N, Hara E. Roles and mechanisms of cellular senescence in regulation of tissue homeostasis. Cancer Sci. 2013;104:525\u201330.","journal-title":"Cancer Sci"},{"key":"260_CR56","doi-asserted-by":"crossref","unstructured":"Yoshimoto S, Loo TM, Atarashi K, Kanda H, Sato S, Oyadomari S, et al. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature. 2013;499:97\u2013101. This is the first evidence of HSC senescence playing a role in liver tumorigenesis.","DOI":"10.1038\/nature12347"},{"key":"260_CR57","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1210\/me.2011-1157","volume":"26","author":"Y Zhang","year":"2012","unstructured":"Zhang Y, Ge X, Heemstra LA, Chen WD, Xu J, Smith JL, et al. Loss of FXR protects against diet-induced obesity and accelerates liver carcinogenesis in ob\/ob mice. Mol Endocrinol. 2012;26:272\u201380.","journal-title":"Mol Endocrinol"},{"key":"260_CR58","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1124\/jpet.111.179390","volume":"338","author":"A Wolfe","year":"2011","unstructured":"Wolfe A, Thomas A, Edwards G, Jaseja R, Guo GL, Apte U. Increased activation of the Wnt\/beta-catenin pathway in spontaneous hepatocellular carcinoma observed in farnesoid X receptor knockout mice. J Pharmacol Exp Ther. 2011;338:12\u201321.","journal-title":"J Pharmacol Exp Ther"},{"key":"260_CR59","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1158\/0008-5472.CAN-06-1078","volume":"67","author":"F Yang","year":"2007","unstructured":"Yang F, Huang X, Yi T, Yen Y, Moore DD, Huang W. Spontaneous development of liver tumors in the absence of the bile acid receptor farnesoid X receptor. Cancer Res. 2007;67:863\u20137.","journal-title":"Cancer Res"},{"key":"260_CR60","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1007\/s10620-011-1707-x","volume":"56","author":"S Liangpunsakul","year":"2011","unstructured":"Liangpunsakul S, Chalasani N. Serum vitamin D concentrations and unexplained elevation in ALT among US adults. Dig Dis Sci. 2011;56:2124\u20139.","journal-title":"Dig Dis Sci"},{"key":"260_CR61","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.numecd.2006.04.002","volume":"17","author":"G Targher","year":"2007","unstructured":"Targher G, Bertolini L, Scala L, Cigolini M, Zenari L, Falezza G, et al. Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease. Nutri, Metabol, Cardiovasc Dis : NMCD. 2007;17:517\u201324.","journal-title":"Nutri, Metabol, Cardiovasc Dis : NMCD"},{"key":"260_CR62","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1038\/bjc.2013.546","volume":"109","author":"JB Wang","year":"2013","unstructured":"Wang JB, Abnet CC, Chen W, Dawsey SM, Fan JH, Yin LY, et al. Association between serum 25(OH) vitamin D, incident liver cancer and chronic liver disease mortality in the Linxian Nutrition Intervention Trials: a nested case-control study. Br J Cancer. 2013;109:1997\u20132004.","journal-title":"Br J Cancer"},{"key":"260_CR63","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1002\/hep.27079","volume":"60","author":"V Fedirko","year":"2014","unstructured":"Fedirko V, Duarte-Salles T, Bamia C, Trichopoulou A, Aleksandrova K, Trichopoulos D, et al. Prediagnostic circulating vitamin D levels and risk of hepatocellular carcinoma in European populations: a nested case-control study. Hepatology. 2014;60:1222\u201330.","journal-title":"Hepatology"},{"key":"260_CR64","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.cell.2013.03.028","volume":"153","author":"N Ding","year":"2013","unstructured":"Ding N, Yu RT, Subramaniam N, Sherman MH, Wilson C, Rao R, et al. A vitamin D receptor\/SMAD genomic circuit gates hepatic fibrotic response. Cell. 2013;153:601\u201313.","journal-title":"Cell"},{"key":"260_CR65","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/hep.24737","volume":"55","author":"CL Roth","year":"2012","unstructured":"Roth CL, Elfers CT, Figlewicz DP, Melhorn SJ, Morton GJ, Hoofnagle A, et al. Vitamin D deficiency in obese rats exacerbates nonalcoholic fatty liver disease and increases hepatic resistin and Toll-like receptor activation. Hepatology. 2012;55:1103\u201311.","journal-title":"Hepatology"},{"key":"260_CR66","first-page":"3757","volume":"28","author":"Z Ghous","year":"2008","unstructured":"Ghous Z, Akhter J, Pourgholami MH, Morris DL. Inhibition of hepatocellular cancer by EB1089: in vitro and in vive study. Anticancer Res. 2008;28:3757\u201361.","journal-title":"Anticancer Res"},{"issue":"574\u2013582","key":"260_CR67","first-page":"e571","volume":"145","author":"S Mudaliar","year":"2013","unstructured":"Mudaliar S, Henry RR, Sanyal AJ, Morrow L, Marschall HU, Kipnes M, et al. Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver disease. Gastroenterology. 2013;145(574\u2013582):e571.","journal-title":"Gastroenterology"},{"key":"260_CR68","unstructured":"Neuschwander-Tetri, B.A., Loomba, R., Sanyal, A.J., Lavine, J.E., Van Natta, M.L., Abdelmalek, M.F., Chalasani, N., Dasarathy, S., Diehl, A.M., Hameed, B., et al. (2014). Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial. Lancet."},{"key":"260_CR69","doi-asserted-by":"crossref","unstructured":"Dapito DH, Mencin A, Gwak GY, Pradere JP, Jang MK, Mederacke I, et al. Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4. Cancer Cell. 2012;21:504\u201316. This study demonstrates LPS-activation of HSC leading to fibrogenesis and tumor growth in NAFLD.","DOI":"10.1016\/j.ccr.2012.02.007"},{"issue":"913\u2013916","key":"260_CR70","volume":"143","author":"A Vrieze","year":"2012","unstructured":"Vrieze A, Van Nood E, Holleman F, Salojarvi J, Kootte RS, Bartelsman JF, et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology. 2012;143(913\u2013916), e917.","journal-title":"Gastroenterology"}],"container-title":["Current Hepatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11901-015-0260-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11901-015-0260-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11901-015-0260-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T21:11:55Z","timestamp":1717881115000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11901-015-0260-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,8]]},"references-count":70,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["260"],"URL":"https:\/\/doi.org\/10.1007\/s11901-015-0260-z","relation":{},"ISSN":["2195-9595"],"issn-type":[{"value":"2195-9595","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,8]]}}}